Summary
Borrelia burgdorferi is a helical drilling machine. Five phases: tick transmission (escapement), dissemination (Stirling differential), immune evasion (OspC/VlsE surface rotation + biofilm + intracellular), chronic persistence (latency engine — 3 distinct PTLDS types), and CNS infiltration (delivery problem: IV Ceftriaxone > oral for BBB crossing). Treatment must match the engine that is running. One antibiotic course ≠ cure.
Treatment Branches
✓ Phase 1-2 Early
Doxy 14–21d · treat on EM rash, don't wait for serology
✓ Immune Evasion
VlsE rotation · biofilm · intracellular residence
✓ PTLDS Type 1
Persistent · Disulfiram / Doxy+Cefoperazone / Daptomycin
✓ PTLDS Type 2
Autoimmune · LDN + hydroxychloroquine, NOT more antibiotics
✓ CNS / Neuro
IV Ceftriaxone 2g/day · 14–28d · facial palsy / radiculopathy
✓ Co-infections
Babesia=Atovaquone · Bartonella=Rifampin+Doxy · Powassan=supportive
Novel Patterns
· NP-LYME-001: Spirochete = helical drilling machine (LAAM coil analogue)
· NP-LYME-002: VlsE surface shuffling = programmatic antigenic rotation
· NP-LYME-003: Biofilm = distributed latency engine (antibiotics miss dormant cells)
· NP-LYME-004: PTLDS = 3 distinct mechanisms conflated as one disease
· NP-LYME-005: Tick saliva = escapement blind spot (IL-10, prostaglandin E2)
· NP-LYME-006: CNS = delivery problem, not killing problem (IV > oral)
· NP-LYME-007: Two-tier serology = late-phase test (30-50% false neg early)
· NP-LYME-008: Treatment failure may = wrong engine, not no disease